The DIGITAL CDMO® Platform
At Andelyn we are diligently working to harness the power of modern technology to maximize the value of data, drive insights into the data, ensure critical data assets are compliant and secured to provide unmatched data insights for clients through The DIGITAL CDMO® Platform.
Setting the Standard
What is different about The DIGITAL CDMO® Platform?
Andelyn Biosciences believes that the “C” in CDMO stands for “collaboration”. Data and technology are key components transcending the industry from one that has been transactional and sometimes combative, historically, to one geared towards partnership and shared successes.
Legacy CDMOs struggle to correlate data from the manufacturing process to lab test results, resulting in inefficiency and lost time.
Data integrity is a chief compliance and security priority. Data Integrity by Design was a primary driver for the implementation approach for The DIGITAL CDMO® Platform. Clients’ data enters a secure chain of custody as part of Andelyn’s electronic assets.
A significant challenge for the biotech community, especially one leveraging multiple partners, including CDMOs, CTOs, and CROs, is contending with disconnected data. It becomes impossible to have complete visibility of a product’s data from its inception and throughout the development lifecycles. Andelyn recognizes that we are a data company in addition to manufacturing gene therapy products. We produce physical products and data for our clients.
The DIGITAL CDMO® Platform brings an optimized result, ranging from higher client satisfaction and the ability to utilize data early in drug development to drive towards optimal production.
Setting Us Apart
What is different about The DIGITAL CDMO® Platform?
Andelyn continues to build out The DIGITAL CDMO® Platform through significant investment in traditional industry-recognized solutions, yet with a design geared towards utilizing the data foundation to provide secure collaboration with our clients as well as build advanced capabilities leveraging AI.
Plasmids
We offer full-scale plasmid DNA manufacturing services for cell and gene therapy, and our reliable, high-quality products ensure the success of our partners. We possess the capability and capacity to manufacture batches of plasmids in any size depending on client specifications – from small trials to clinical-scale plasmid production.
Viral Vectors
Our Viral Vector Core comprises laboratory space reserved to manufacture research grade AAV vectors that support preclinical studies such as pilot, proof-of-concept, dose confirmation and IND-enabling toxicology studies.
Our Facilities
Our three facilities in Columbus, OH, are meticulously designed to support your project's evolution from concept to reality. We're not just about meeting today's needs but also about anticipating the demands of the future with ample capacity to support our clients today and the ability to expand our operations as needed.
Explore the unique role each of our purpose-built centers plays in advancing gene therapies, setting new industry standards for excellence and partnership.